These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38167591)

  • 1. Comparison of perceptions in Canada and USA regarding cannabis and edibles.
    Music J; Sterling B; Charlebois S; Goedhart C
    J Cannabis Res; 2024 Jan; 6(1):1. PubMed ID: 38167591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative analysis of laws on recreational cannabis edibles between Canada and the United States of America.
    Goundar P; Macaulay T; Szafron M
    Int J Drug Policy; 2021 Aug; 94():103191. PubMed ID: 33756442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets.
    Goodman S; Wadsworth E; Leos-Toro C; Hammond D;
    Int J Drug Policy; 2020 Feb; 76():102658. PubMed ID: 31927413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noticing of cannabis health warning labels in Canada and the US.
    Goodman S; Hammond D
    Health Promot Chronic Dis Prev Can; 2021; 41(7-8):201-210. PubMed ID: 34427418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-medical cannabis in North America: an overview of regulatory approaches.
    Lancione S; Wade K; Windle SB; Filion KB; Thombs BD; Eisenberg MJ
    Public Health; 2020 Jan; 178():7-14. PubMed ID: 31600630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-Use, Simultaneous Use, and Mixing of Cannabis and Tobacco: A Cross-National Comparison of Canada and the US by Cannabis Administration Type.
    Chu A; Chaiton M; Kaufman P; Goodwin RD; Lin J; Hindocha C; Goodman S; Hammond D
    Int J Environ Res Public Health; 2023 Feb; 20(5):. PubMed ID: 36901216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. THC labeling on cannabis products: an experimental study of approaches for labeling THC servings on cannabis edibles.
    Goodman S; Hammond D
    J Cannabis Res; 2022 Apr; 4(1):17. PubMed ID: 35387681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis use for symptom relief in multiple sclerosis: A cross-sectional survey of webinar attendees in the US and Canada.
    Hildebrand A; Minnier J; Cameron MH
    Mult Scler Relat Disord; 2020 Feb; 38():101516. PubMed ID: 31855842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of select cannabis use and supply indicators pre- and post-legalization in Canada.
    Fischer B; Lee A; Robinson T; Hall W
    Subst Abuse Treat Prev Policy; 2021 Oct; 16(1):77. PubMed ID: 34620191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in the use of cannabis products in Canada and the USA, 2018 - 2020: Findings from the International Cannabis Policy Study.
    Hammond D; Goodman S; Wadsworth E; Freeman TP; Kilmer B; Schauer G; Pacula RL; Hall W
    Int J Drug Policy; 2022 Jul; 105():103716. PubMed ID: 35613480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consumer perceptions of legal cannabis products in Canada, 2019-2021: a repeat cross-sectional study.
    Wadsworth E; Fataar F; Goodman S; Smith DM; Renard J; Gabrys R; Jesseman R; Hammond D
    BMC Public Health; 2022 Nov; 22(1):2048. PubMed ID: 36348479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of legalization of access to recreational Cannabis on Canadian medical users with Cancer.
    Hawley P; Gobbo M; Afghari N
    BMC Health Serv Res; 2020 Oct; 20(1):977. PubMed ID: 33109169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Legal status of recreational cannabis and self-reported substitution of cannabis for opioids or prescription pain medication in Canada and the United States.
    Wadsworth E; Hines LA; Hammond D
    Subst Abus; 2022; 43(1):943-948. PubMed ID: 35420977
    [No Abstract]   [Full Text] [Related]  

  • 14. Perceived access to cannabis and ease of purchasing cannabis in retail stores in Canada immediately before and one year after legalization.
    Wadsworth E; Driezen P; Chan G; Hall W; Hammond D
    Am J Drug Alcohol Abuse; 2022 Mar; 48(2):195-205. PubMed ID: 35157544
    [No Abstract]   [Full Text] [Related]  

  • 15. Canada's Recreational Cannabis Legalization and Medical Cannabis Patient Activity, 2017-2022.
    Armstrong MJ
    Am J Public Health; 2024 Nov; 114(S8):S673-S680. PubMed ID: 39361903
    [No Abstract]   [Full Text] [Related]  

  • 16. Exploring consumer preferences for cannabis edible products to support public health policy: A discrete choice experiment.
    Donnan J; Johnston K; Coombs M; Najafizada M; Bishop L
    PLoS One; 2024; 19(5):e0292336. PubMed ID: 38753807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse outcomes of cannabis use in Canada, before and after legalisation of non-medical cannabis: cross-sectional analysis of the International Cannabis Policy Study.
    Marquette A; Iraniparast M; Hammond D
    BMJ Open; 2024 Jan; 14(1):e077908. PubMed ID: 38171626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between recreational cannabis legalization and cannabis-related emergency department visits by age, gender, and geographic status in Ontario, Canada: An interrupted time series study.
    Kim C; Chum A; Nielsen A; Allin S; Penney TL; Rittenbach K; MacMaster FP; O'Campo P
    PLoS One; 2022; 17(10):e0268718. PubMed ID: 36288275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric Hospitalizations for Unintentional Cannabis Poisonings and All-Cause Poisonings Associated With Edible Cannabis Product Legalization and Sales in Canada.
    Myran DT; Tanuseputro P; Auger N; Konikoff L; Talarico R; Finkelstein Y
    JAMA Health Forum; 2023 Jan; 4(1):e225041. PubMed ID: 36637814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Canadian Cannabis Act legalizes and regulates recreational cannabis use in 2018.
    Cox C
    Health Policy; 2018 Mar; 122(3):205-209. PubMed ID: 29429644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.